City
Companies in Palo Alto
VCMC tracks 1,645 companies based in Palo Alto. 339 of them have raised a venture or growth round, $82.82B in total, with a median round of $16M; 161 raised since 2024. 328 of the 339 have a VCMC valuation; the median is $112M.
1,645
companies tracked
339
venture-backed
21% of those tracked
$82.82B
raised in total
by 331 companies
$16M
median round
of 581 rounds with an amount
$112M
median valuation
of 328 companies valued
Values cover private companies only; public companies are not included.
By their latest round, most are at Seed (99 of 339).
- Pre-seed 8
- Seed 99
- Series A 98
- Series B 64
- Series C and later 69
- Stage not stated 1
The companies
Companies in Palo Alto
The 50 venture-backed companies below are this page's list; Safe Superintelligence has raised the most ($8.00B).
| # | Last round | History | Range | Trend | Grade | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Safe Superintelligence Tech Companies | Growth Equity Jul 2026 $5.00B | $50.2B | $35.1B – $77.7B | $54.7B (+9%) | $4.9B | 0% | 35 | growing | B | |
| 2 | Point Loans & Financing | Debt Dec 2025 $2.50B | $837M | $287M – $1.8B | $818M (-2%) | $141M | 17% | 542 | growing | C | |
| 3 | PsiQuantum Semiconductors | Grant Jul 2026 $125M | $9.6B | $6.0B – $11.0B | $9.6B (0%) | $1.1B | 0% | 671 | up | B | |
| 4 | SandboxAQ Software Development Services | Grant Jun 2026 $500M | $8.7B | $4.4B – $12.4B | $8.7B (0%) | $958M | 0% | 375 | up | B | |
| 5 | Luma AI Tech Companies | Series C Nov 2025 $900M | $4.8B | $3.5B – $5.6B | $4.5B (-5%) | $572M | 27% | 191 | flat | A | |
| 6 | Uniphore Tech Companies | Series F Oct 2025 $260M | $3.2B | $2.2B – $3.7B | $3.2B (-1%) | $358M | 2% | 880 | flat | A | |
| 7 | Plume Tech Companies | Growth Equity Oct 2021 $300M | $931M | $239M – $2.8B | $836M (-10%) | $249M | 50% | 498 | up | D | |
| 8 | PaleBlueDot AI Hosting & Cloud Infrastructure Providers | Series C Oct 2026 $200M | $3.3B | $2.8B – $4.8B | $4.2B (+28%) | $458M | 0% | 28 | growing | A | |
| 9 | Medable Tech Companies | Series D Oct 2021 $304M | $1.1B | $158M – $2.6B | $1.1B (-5%) | $271M | 36% | 344 | flat | D | |
| 10 | ALSO Automobile Dealers & Manufacturers | Series D Aug 2026 $150M | $2.0B | $1.2B – $3.7B | $2.4B (+24%) | $268M | 0% | 372 | growing | B | |
| 11 | Owner Tech Companies | Series D Aug 2026 $240M | $2.4B | $2.0B – $3.4B | $3.0B (+25%) | $329M | 0% | 462 | growing | A | |
| 12 | Workato Tech Companies | Series E Nov 2021 $200M | $6.8B | $917M – $9.5B | $6.7B (-1%) | $940M | 0% | 1,470 | up | D | |
| 13 | Medical Supply Manufacturers | Series B Jul 2022 $225M | $407M | $146M – $2.1B | $324M (-20%) | $259M | 91% | 152 | down | D | |
| 14 | Biotechnology | Growth Equity Aug 2024 $300M | $8.0B | $4.1B – $12.2B | $4.7B (-41%) | $721M | 0% | 105 | growing | B | |
| 15 | Biotechnology | Series B Dec 2024 $161M | $958M | $468M – $1.9B | $690M (-28%) | $186M | 94% | 22 | down | C | |
| 16 | Medical Supply Manufacturers | Series C Mar 2026 $50M | $552M | $310M – $935M | $614M (+11%) | $67.5M | 0% | 25 | growing | B | |
| 17 | Jerry Insurance - Agents, Carriers & Brokers | Series C Aug 2021 $75M | $475M | $188M – $1.1B | $438M (-8%) | $105M | 39% | 401 | growing | C | |
| 18 | Biotechnology | Growth Equity Sep 2023 $100M | $490M | $151M – $1.8B | $386M (-21%) | $118M | 59% | 54 | down | D | |
| 19 | Cybersecurity | Acquisition Nov 2025 | $174M acquired 2025 | $81.9M – $581M | – | – | 97% | 94 | shrinking | C | |
| 20 | Biotechnology | Series B Mar 2021 $73M | $52.8M | $26.2M – $190M | $51.2M (-3%) | $81.9M | 97% | 12 | shrinking | C | |
| 21 | Tech Companies | Series B Jun 2019 $50M | $218M | $19.3M – $390M | $205M (-6%) | $45.1M | 16% | 170 | flat | D | |
| 22 | Biotechnology | Series A Dec 2021 $68M | $86.6M | $23.7M – $871M | $86.0M (-1%) | $114M | 92% | 21 | down | D | |
| 23 | Tech Companies | Series D Feb 2021 $46M | $188M | $30.4M – $961M | $169M (-10%) | $77.4M | 59% | 73 | down | D | |
| 24 | Tech Companies | Series A Jul 2025 $51M | $533M | $218M – $756M | $533M (0%) | $74.6M | 0% | 156 | growing | C | |
| 25 | Tech Companies | Series B Aug 2022 $66M | $1.0B | $120M – $1.4B | $958M (-5%) | $143M | 0% | 183 | up | D | |
| 26 | Tech Companies | Series C Mar 2021 $45M | $129M | $23.7M – $694M | $115M (-11%) | $59.2M | 63% | 134 | down | D | |
| 27 | Tech Companies | Series D Feb 2020 $50M | $161M | $35.4M – $788M | $161M (0%) | $89.4M | 70% | 148 | flat | D | |
| 28 | Tech Companies | Series C Mar 2021 $40M | $246M | $28.9M – $497M | $230M (-6%) | $47.6M | 32% | – | unknown | D | |
| 29 | Tech Companies | Series C Jan 2026 $30M | $302M | $176M – $461M | $325M (+7%) | $35.7M | 0% | 117 | up | B | |
| 30 | Tech Companies | Series B Mar 2023 $43M | $359M | $132M – $577M | $359M (0%) | $44.8M | 0% | 223 | growing | C | |
| 31 | Tech Companies | Series B Mar 2025 $20M | $323M | $135M – $371M | $323M (0%) | $35.5M | 0% | 155 | unknown | B | |
| 32 | Tech Companies | Series B Jan 2024 $25M | $298M | $93.3M – $423M | $214M (-28%) | $32.8M | 0% | 170 | up | C | |
| 33 | Tech Companies | Other May 2026 $20M | $147M | $32.2M – $320M | $115M (-22%) | $25.8M | 37% | 99 | flat | D | |
| 34 | Biotechnology | Series A Jul 2026 $24M | $131M | $85.5M – $202M | $119M (-9%) | $32.8M | 97% | 17 | shrinking | B | |
| 35 | Medical Supply Manufacturers | Other Dec 2025 $10M | $227M | $77.1M – $345M | $227M (0%) | $40.8M | 0% | 44 | growing | C | |
| 36 | Biotechnology | Growth Equity May 2026 $26M | $300M | $190M – $484M | $318M (+6%) | $28.6M | 0% | 50 | flat | B | |
| 37 | Biotechnology | Seed Sep 2025 $25M | $400M | $132M – $609M | $400M (0%) | $72.0M | 0% | 16 | growing | C | |
| 38 | Biotechnology | Series A May 2026 $20M | $147M | $73.9M – $308M | $203M (+37%) | $28.4M | 0% | 18 | up | C | |
| 39 | Biotechnology | Series A Sep 2026 $10M | $58.9M | $36.5M – $152M | $100M (+70%) | $14.0M | 0% | 49 | up | C | |
| 40 | Pharmaceutical Products | Seed Apr 2022 $16M | $178M | $7.01M – $271M | $178M (0%) | $32.0M | 0% | 4 | unknown | D | |
| 41 | Biotechnology | Other Oct 2024 $5.0M | $92.3M | $9.35M – $182M | $86.3M (-6%) | $22.1M | 0% | 17 | up | D | |
| 42 | Medical Supply Manufacturers | Series A Jan 2022 $13M | $91.6M | $3.47M – $198M | $91.6M (0%) | $18.2M | 0% | 7 | unknown | D | |
| 43 | Medical Supply Manufacturers | Series B Jan 2018 $13M | $139M | $6.10M – $212M | $139M (0%) | $15.3M | 0% | 6 | unknown | D | |
| 44 | Biotechnology | Series A May 2022 $11M | $96.0M | $4.40M – $217M | $96.0M (0%) | $19.9M | 0% | 4 | unknown | D | |
| 45 | Civil Engineering Services | Seed Oct 2025 $10M | $144M | $47.9M – $222M | $146M (+1%) | $26.2M | 0% | 36 | growing | C | |
| 46 | Biotechnology | Seed Dec 2021 $7.9M | $0.44M | $0 – $0.44M | $0.44M (0%) | – | 100% | 2 | unknown | dead | |
| 47 | Medical Supply Manufacturers | Series A May 2019 $5.0M | $83.3M | $1.83M – $253M | $79.6M (-4%) | $7.00M | 8% | 260 | flat | D | |
| 48 | Pharmaceutical Products | Series B Dec 2012 $3.0M | $2.74M | $1.41M – $7.19M | $2.74M (0%) | $3.54M | 97% | 10 | shrinking | C | |
| 49 | Pharmaceutical Products | Seed Dec 2023 $3.0M | $12.6M | $3.22M – $32.8M | $9.50M (-25%) | $5.47M | 59% | 2 | unknown | D | |
| 50 | Recruitment & Job Listing Services | Seed Jan 2023 $1.3M | $12.0M | $0.95M – $27.3M | $11.1M (-8%) | $2.82M | 33% | 14 | flat | D |
Showing 50 of 1,645. Load more lists every other company here, 50 at a time.
Valuations
How these companies are valued
328 of the 339 venture-backed companies here have a VCMC valuation; the median is $112M. A company acquired after its last round keeps its last value as a private company and is left out of the median. 57 companies have disclosed a valuation; for the rest VCMC's valuation is the only number. Each valuation comes with a range, from a low to a high scenario, and a prediction for a year from now. Values cover private companies only; public companies are not included. How VCMC values companies.
Investors
Who backs them
Firms that backed two or more of these companies. Insight Partners backed 17, Y Combinator 16.
- Insight Partners 17 companies, led 11
- Y Combinator 16 companies, led 2
- Andreessen Horowitz 15 companies, led 7
- Lightspeed Venture Partners 15 companies, led 7
- Sequoia Capital 15 companies, led 5
- Accel 12 companies, led 8
- Norwest 11 companies, led 5
- Khosla Ventures 10 companies, led 8
- General Catalyst 10 companies, led 2
- 10 companies
- Foundation Capital 9 companies, led 5
- Gaingels 9 companies
Recent rounds
Latest funding
66 rounds from Oct 2025 to Sep 2026, $28.62B with a disclosed amount.
- Series A, led by Inovia $15M 21 Sep 2026
- Series A, led by LB Investment $10M 18 Sep 2026
- Seed, led by Corazon Capital $7.0M 16 Sep 2026
- Growth, led by FTV Management Company $155M 2 Sep 2026
- Owner Series D, led by Goldman Sachs Alternatives $240M 28 Aug 2026
- Series A, led by OnDean $14M 24 Aug 2026
- ALSO Series D, led by Prysm Capital $150M 19 Aug 2026
- Seed, with Id4 Ventures and TQ Ventures $30M 13 Aug 2026
- Series B, with Khosla Ventures and Galvanize $37M 5 Aug 2026
- Series A, led by Ardenwood Ventures $20M 1 Aug 2026
- Seed, led by Field Ventures $5.0M 27 Jul 2026
- Safe Superintelligence Growth, led by Nvidia Corp. $5.00B 27 Jul 2026
Browse
Related groups
Industries in Palo Alto
Region
Other cities in United States
Questions
Frequently asked
How many companies in Palo Alto does VCMC track?
1,645. 339 of them have raised a venture or growth round.
How much have companies in Palo Alto raised?
$82.82B in total across the 331 with a known amount; the median round is $16M. 161 raised a round since 2024.
Which companies in Palo Alto have raised the most?
Safe Superintelligence ($8.00B), Point ($2.66B), PsiQuantum ($2.50B).
Which investors back companies in Palo Alto most often?
Insight Partners (17 companies), Y Combinator (16 companies), Andreessen Horowitz (15 companies).
What are companies in Palo Alto worth?
The median VCMC valuation is $112M across 328 companies; companies acquired after their last round are left out. Values cover private companies only; public companies are not included.
What was the latest funding round?
Feldera raised a Series A round of $15M (Sep 2026), led by Inovia.